WANGARATTA'S ongoing rollout of the AstraZeneca vaccine appears to have been largely unaffected by new findings made public by the Australian Government last week.
The Australian Technical Advisory Group on Immunisation (ATAGI) recently stated there was evidence of a rare but serious side effect involving thrombosis (clotting) with thrombocytopenia (low blood platelet count), following receipt of...
